About Unosource Pharma Limited
Data last updated: 05 January 2026
Unosource Pharma Limited is a public limited company based in Delhi, Delhi, India, a subsidiary of Akums Drugs And Pharmaceuticals Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 18 December 2013, the company has been in operation for over 13 years.
Registered with ROC Delhi under CIN U24233DL2013PLC262364.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹18.02 Cr. It is led by directors including Sanjay Chandrakant Chalke and Manju Bist.
Last AGM: 15 June 2025. Financial statements filed for year ended 31 March 2025. Office: 305 Third Floor C – Block Plot No. 5 Mohan Place Saraswati Vihar, Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹147.51 Cr, a growth of 14% compared to the previous year.
The company has a workforce of approximately 41 employees as per the latest available data. It operates as a subsidiary of Akums Drugs And Pharmaceuticals Limited.
The company is associated with 2 brands - Akums, Unosource Pharma. As per MCA filings, the company has open charges of ₹20 Cr and satisfied charges of ₹7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unosourcepharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address305 Third Floor C – Block Plot No. 5 Mohan Place Saraswati Vihar, Delhi, Delhi, India – 110034
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Unosource Pharma Limited
Unosource Pharma Limited operates two associated brands: Akums and Unosource Pharma. These brands represent Unosource Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| CDMO focusing on spectrum of dosage forms and therapeutic segments | akums.in | |
| Pharmaceutical manufacturing, exporting, and CDMO services. | unosourcepharma.com |
Competitors & Alternatives of Unosource Pharma Limited
Brands and companies operating in the same space as Unosource Pharma Limited include Jubilant Life Sciences, Nectar Lifesciences, Windlas and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
|
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
|
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
|
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
|
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
|
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
|
|
CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | Starnberg, Germany, Germany | 2008 |
|
|
APIs and finished drugs are developed and manufactured in pharmaceuticals. | Bresso, Italy, Italy | 1906 |
|
|
Proprietary stabilizing solutions for biologics formulations are developed. | Munich, Germany, Germany | 2003 |
Business Activity of Unosource Pharma Limited
Unosource Pharma Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details for Unosource Pharma Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Unosource Pharma Limited
Unosource Pharma Limited is audited by Walker Chandiok & Co. LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Walker Chandiok & Co. LLP | Locked | Locked | Locked |
Complete auditor history for Unosource Pharma Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Unosource Pharma Limited
Unosource Pharma Limited currently reports 3 directors and 1 key managerial person. 16 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Chandrakant Chalke | Director | 13 Jan 2017 | 9 Years 7 Months | Current |
| Manju Bist | Director | 20 Aug 2024 | 1 Years 11 Months | Current |
|
Sumeet Sood
Also directs:
Qualymed Pharma Private Limited
|
Cfo | 10 Jun 2022 | 4 Years 2 Months | Current |
| Manmohan Singh | Director | 15 Jun 2015 | 11 Years 1 Months | Current |
Financials of Unosource Pharma Limited FY 2025 filings available
Unosource Pharma Limited reported revenue of ₹147.51 Cr (up 14.00% YoY) for FY 2025.
Ten-year financial statements for Unosource Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Unosource Pharma Limited
Shareholding and ownership data for Unosource Pharma Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Unosource Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2025 | Hdfc Bank Limited | ₹5 Cr | Open |
| 11 Sep 2023 | Others | ₹5 Cr | Open |
| 14 Jul 2023 | The Hongkong and Shanghai Banking Corporation Limited | ₹5 Cr | Open |
| 16 Dec 2022 | Citi Bank N.A. | ₹5 Cr | Open |
| 02 Apr 2018 | Yes Bank Limited | ₹5 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Unosource Pharma Limited
Unosource Pharma Limited has a workforce of 41 employees as of Apr 09, 2024.
Employee and EPFO history for Unosource Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Unosource Pharma Limited
GST registrations and filing compliance for Unosource Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Unosource Pharma Limited
Credit ratings, litigation, and regulatory alerts for Unosource Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Unosource Pharma Limited
MSME payment history for Unosource Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unosource Pharma Limited
Corporate group structure for Unosource Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unosource Pharma Limited
MCA filings and documents for Unosource Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Unosource Pharma Limited
Frequently Asked Questions about Unosource Pharma Limited
Unosource Pharma Limited is an active public limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 18 December 2013 (13+ years old) and is registered under CIN U24233DL2013PLC262364. The company has 41 employees.
Unosource Pharma Limited reported revenue of ₹147.51 Cr for FY 2025 (up 14.00% YoY).
The current directors and KMP of Unosource Pharma Limited are:
- Sanjay Chandrakant Chalke - Director
- Manju Bist - Director
- Sumeet Sood - Cfo
- Manmohan Singh - Director
The primary industry of Unosource Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Unosource Pharma Limited can be reached at the registered office: 305 Third Floor C – Block Plot No. 5 Mohan Place Saraswati Vihar, Delhi, Delhi, India – 110034, or through the website unosourcepharma.com.
The authorised capital is ₹20 Cr, and the paid-up capital is ₹18.02 Cr.